価格表

在庫・価格 : 2024年05月04日 08時45分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Bcl-XL, Human, DuoSet IC Kit (2 plates)
データシート※最新のデータシートでない場合があります
DYC894-2 RSDアールアンドディー システムス
R&D Systems, Inc.
1 kit ¥83,000
(未発注)
追加

在庫・価格 : 2024年05月04日 08時45分 現在

Bcl-XL, Human, DuoSet IC Kit (2 plates)

  • 商品コード:DYC894-2
  • メーカー:RSD
  • 包装:1kit
  • 価格: ¥83,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Kells AP et al. AAV-mediated expression of Bcl-xL or XIAP fails to induce neuronal resistance against quinolinic acid-induced striatal lesioning. Neurosci. Lett. 2008 May;436(3):326-30
Kells AP et al
2008/01/01
Species: Rat, Application: Homogenized Tissue - Protocol Included PubMed
2 Mu P et al. Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer. Int. J. Cancer 2009 Dec;125(12):2978-90
Mu P et al
2009/01/01
Sample Type: Homogenized Tissue PubMed
3 Poggi A et al. Engagement of CD31 delivers an activating signal that contributes to the survival of chronic lymphocytic leukaemia cells. Br. J. Haematol. 2010 Nov;151(3):252-64
Poggi A et al
2010/01/01
Sample Type: Cell Lysates PubMed
4 Kraemer BF et al. Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets. Blood 2012 Dec;120(25):5014-20
Kraemer BF et al
2012/01/01
Sample Type: whole cells PubMed
  • No.: 1
  • 文献情報:
    Kells AP et al. AAV-mediated expression of Bcl-xL or XIAP fails to induce neuronal resistance against quinolinic acid-induced striatal lesioning. Neurosci. Lett. 2008 May;436(3):326-30
    Kells AP et al
    2008/01/01
  • 備考:
    Species: Rat, Application: Homogenized Tissue - Protocol Included
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Mu P et al. Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer. Int. J. Cancer 2009 Dec;125(12):2978-90
    Mu P et al
    2009/01/01
  • 備考:
    Sample Type: Homogenized Tissue
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Poggi A et al. Engagement of CD31 delivers an activating signal that contributes to the survival of chronic lymphocytic leukaemia cells. Br. J. Haematol. 2010 Nov;151(3):252-64
    Poggi A et al
    2010/01/01
  • 備考:
    Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Kraemer BF et al. Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets. Blood 2012 Dec;120(25):5014-20
    Kraemer BF et al
    2012/01/01
  • 備考:
    Sample Type: whole cells
  • 参照:
    PubMed